We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Beckman Coulter Acquires Siemens Healthcare Diagnostics’ Clinical Microbiology Business

Beckman Coulter an indirect wholly-owned subsidiary of Danaher Corp.has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics. More...
24 Jul 2014

IDT Acquires SURVEYOR Nuclease Product Line from Transgenomic

The SURVEYOR line is to be used by Integrated DNA Technologies primarily to support researchers performing mutation detection and potentially-clinical genome editing, and by Transgenomic primarily to support diagnostic and other clinical applications.  More...
13 Jul 2014

Fewer Regulatory Barriers in Europe Benefit Companion Diagnostics Sector

The growth in personalized medicine has led to increased interest in companion diagnostics tests or tests that match the right therapy to the patient.  More...
01 Jul 2014

Biocartis and Abbott Enter Exclusive Partnership to Develop Multiplex Companion Diagnostics

The new collaboration between Biocartis and Abbott Laboratories is expected to fuel new pharmaceutical partnerships for companion diagnostics programs.   More...
30 Jun 2014

Gene Expression Profiling Drives Personalized Medicine Worldwide

Large amounts of data generated by gene expression profiling should increase implementation of information management tools, according to recent market research.   More...
17 Jun 2014

Rosetta and Moffitt Partner to Develop microRNA Cancer Diagnostic

Rosetta Genomics, a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, has entered into an agreement with Moffitt Cancer Center to advance the development and commercialization of Rosetta's thyroid neoplasia assay.   More...
16 Jun 2014

Sequenom Sells Bioscience Unit to Agena

Sequenom has sold its Bioscience business for up-to-USD 35.8 million to Agena Bioscience, which said it plans to expand clinical use of the Massarray System for mass spectrometry-based detection of nucleic acids.  More...
11 Jun 2014
New
Gold Member
Automated Clinical Chemistry Analyzer
Envoy 500+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Steam Sterilizer
Hi Vac II Line
New
Total Laboratory Automation Solution
SATLARS Mini T8


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
INTEGRA BIOSCIENCES AG